Before starting the combination , consult your GP or specialist if: You have diabetes or prediabetes your glucose-lowering regimen may need adjustment You have a history of pancreatitis semaglutide carries warnings about pancreatitis risk [1] You experience severe gastrointestinal symptoms on Wegovycorticosteroids can affect the GI tract You are taking multiple medications comprehensive review prevents overlooked interactions During concurrent therapy , seek medical advice if you experience: Persistent hyperglycaemia blood glucose consistently above target despite medication adherence Symptoms of diabetes excessive thirst, frequent urination, unexplained fatigue, or blurred vision Severe gastrointestinal symptoms persistent nausea, vomiting, or abdominal pain, which could indicate pancreatitis or other complications (seek urgent same-day assessment or go to A&E for severe, persistent abdominal pain with vomiting
To reach your goals with bariatric surgery
It forces the system to recalibrate again, often producing renewed weight loss in people who had completely stalled on compounded tirzepatide
The US Food and Drug Administration has now approved both medications for treatment of patients with obesity, even if they do not have diabetes
The drug, which contains semaglutide, has been linked to serious gastrointestinal conditions like gastroparesis and pancreatitis